A Liposome Changes How Neferine Crosses Skin
A neferine liposome study connects formulation design with skin permeation and observations in a mouse photoaging model.
The same active, two formulations
Neferine, an alkaloid from lotus seed embryos, has attracted interest for its potential in skin research. Its poor water solubility presents a formulation question: how can it be carried across the skin barrier? A 2026 study by researchers including a team at the First Affiliated Hospital of Xi’an Jiaotong University explored a liposome-based gel and compared it with free neferine. [1]
The researchers prepared liposomes with an average diameter of approximately 138 nanometres and an encapsulation efficiency of about 69%. They then placed either free neferine or the liposomal formulation in a gel, each at 0.1% concentration. [1]
Measuring what crosses the skin
Using full-thickness excised rat skin in Franz diffusion cells, the team measured neferine reaching a receptor solution over 24 hours. Cumulative permeation was higher for the liposomal formulation than for free neferine. The two gels contained the same concentration of active, making the carrier a central feature of the comparison. [1]
This measurement follows material through the full skin sample into the receptor solution. For a product intended to act locally, an additional question is where and how much active remains within the skin. Permeation and tissue distribution can therefore inform different formulation decisions.
From permeation to a photoaging model
The team also studied 24 mice divided into four groups, including an unirradiated control and three UVA-exposed groups receiving blank gel, free neferine gel or liposomal neferine gel. After six weeks of UVA exposure, the liposomal group showed improvements in epidermal thickness and collagen structure relative to the irradiated blank-gel group. The experiment did not include an empty-liposome control under UVA exposure. [1]
In human dermal fibroblasts exposed to UVA, researchers observed changes in oxidative-stress and senescence-related markers after treatment. Together, the experiments connect a formulation comparison with tissue and cell observations, each at a different stage of research. [1]
For formulation teams, the study illustrates why a promising active is also a delivery-design problem. The next useful measurement depends on the intended application: crossing skin, remaining in a target region, and producing a biological response are related but distinct questions.